Tuesday, May 7, 2013

FDA approves first GMO flu vaccine containing reprogrammed insect virus

FDA approves first GMO flu vaccine containing reprogrammed insect virus 

A new vaccine for influenza has hit the market, and it is the first ever to contain genetically-modified (GM) proteins derived from insect cells. According to reports, the U.S. Food and Drug Administration (FDA) recently approved the vaccine, known as Flublok, which contains recombinant DNA technology and an insect virus known as baculovirus that is purported to help facilitate the more rapid production of vaccines.

According to Flublok's package insert, the vaccine is trivalent, which means it contains GM proteins from three different flu strains. The vaccine's manufacturer, Protein Sciences Corporation (PSC), explains that Flublok is produced by extracting cells from the fall armyworm, a type of caterpillar, and genetically altering them to produce large amounts of hemagglutinin, a flu virus protein that enables the flu virus itself to enter the body quickly.
http://www.naturalnews.com/039013_flu_vaccine_insect_virus_GMOs.html#ixzz2Se16LLFg

• Two vaccine study participants die during trials of the first GMO flu vaccine
Flublok, a new vaccine for influenza, is now available and is the first vaccine ever to contain genetically-modified (GM) proteins derived from insect cells. Flublok is trivalent, which means it contains GM proteins from three different influenza strains. According to clinical data provided in the vaccine's package insert by its manufacturer, the Protein Sciences Corporation (PSC), two study participants actually died during trials of the vaccine.

The nerve disease Guillain-Barre Syndrome (GSB) is listed on the shot as a potential side effect. The "Warnings and Precautions," section of the vaccine's literature states, "If Guillain-Barre Syndrome (GBS) has occurred within six weeks of receipt of a prior influenza vaccine, the decision to give Flublock should be based on careful consideration of the potential benefits and risks." Other possible side effects include allergic reactions, respiratory infections, headaches, fatigue, altered immunocompetence, rhinorrhea, and myalgia.
http://www.examiner.com/article/two-vaccine-study-participants-die-during-trials-of-the-first-gmo-flu-vaccine

• FDA Approves First GMO Flu Vaccine Containing Reprogrammed Insect Virus
http://www.infowars.com/fda-approves-first-gmo-flu-vaccine-containing-reprogrammed-insect-virus/

• First Genetically Engineered Flu Vaccine Now on the Market
http://healthimpactnews.com/2013/first-genetically-engineered-flu-vaccine-now-on-the-market/

Posted by @[593190386:2048:Julie]
Join us! www.facebook.com/thenwowillfail
Listen to our daily show 5PM PST/ 7PM ESThttp://www.blogtalkradio.com/thenwowillfail
FDA approves first GMO flu vaccine containing reprogrammed insect virus

A new vaccine for influenza has hit the market, and it is the first ever to contain genetically-modified (GM) proteins derived from insect cells. According to reports, the U.S. Food and Drug Administration (FDA) recently approved the vaccine, known as Flublok, which contains recombinant DNA technology and an insect virus known as baculovirus that is purported to help facilitate the more rapid production of vaccines.

According to Flublok's package insert, the vaccine is trivalent, which means it contains GM proteins from three different flu strains. The vaccine's manufacturer, Protein Sciences Corporation (PSC), explains that Flublok is produced by extracting cells from the fall armyworm, a type of caterpillar, and genetically altering them to produce large amounts of hemagglutinin, a flu virus protein that enables the flu virus itself to enter the body quickly.
http://www.naturalnews.com/039013_flu_vaccine_insect_virus_GMOs.html#ixzz2Se16LLFg

• Two vaccine study participants die during trials of the first GMO flu vaccine
Flublok, a new vaccine for influenza, is now available and is the first vaccine ever to contain genetically-modified (GM) proteins derived from insect cells. Flublok is trivalent, which means it contains GM proteins from three different influenza strains. According to clinical data provided in the vaccine's package insert by its manufacturer, the Protein Sciences Corporation (PSC), two study participants actually died during trials of the vaccine.

The nerve disease Guillain-Barre Syndrome (GSB) is listed on the shot as a potential side effect. The "Warnings and Precautions," section of the vaccine's literature states, "If Guillain-Barre Syndrome (GBS) has occurred within six weeks of receipt of a prior influenza vaccine, the decision to give Flublock should be based on careful consideration of the potential benefits and risks." Other possible side effects include allergic reactions, respiratory infections, headaches, fatigue, altered immunocompetence, rhinorrhea, and myalgia.
http://www.examiner.com/article/two-vaccine-study-participants-die-during-trials-of-the-first-gmo-flu-vaccine

• FDA Approves First GMO Flu Vaccine Containing Reprogrammed Insect Virus
http://www.infowars.com/fda-approves-first-gmo-flu-vaccine-containing-reprogrammed-insect-virus/

• First Genetically Engineered Flu Vaccine Now on the Market
http://healthimpactnews.com/2013/first-genetically-engineered-flu-vaccine-now-on-the-market/

Posted by Julie
Join us! www.facebook.com/thenwowillfail
Listen to our daily show 5PM PST/ 7PM ESThttp://www.blogtalkradio.com/thenwowillfail

1 comment:

Unknown said...

Promoting vaccine research is one of the major challenges arising in health sector faced by the developing countries. rotavirus vaccine | vaccine manufacture | vaccine optimization